학술논문

Continued 5α-reductase inhibitor use after prostate cancer diagnosis and the risk of reclassification and adverse pathological outcomes in the PASS
Document Type
Article
Source
In: Journal of Urology. (Journal of Urology, 1 January 2019, 201(1):106-111)
Subject
Language
English
ISSN
15273792
00225347